Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...
Evaluation of Chimeric Antigen Receptor Design To Identify Affinity and Spatial Binding Requirements
Chimeric antigen receptors (CARs) are artificial immunoreceptors that drive T cell-mediated tumor destruction. CAR-modified T cells have demonstrated unprecedented clinical success, leading to six FDA ...
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...
Subscribe to our newsletter for the latest sci-tech news updates. Proteins that respond to external stimuli function as molecular switches, playing a vital role in the precise regulation of biological ...
Professor Zhaohui Tang and Associate Professor Zhilin Liu from the team of Professor Xuesi Chen at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, developed ...
Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.
The remote control doesn’t trigger the self-destruction of the CAR T cells, but simply prompts them to disengage from their cancerous targets.
Antibodies are one of the most specific tools for the detection and capture of molecular targets. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results